Cargando…

Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development

BACKGROUND: Down syndrome is a chromosomal disorder caused by the presence of three copies of chromosome 21. The mechanisms by which this aneuploidy produces the complex and variable phenotype observed in people with Down syndrome are still under discussion. Recent studies have demonstrated an incre...

Descripción completa

Detalles Bibliográficos
Autores principales: Laffaire, Julien, Rivals, Isabelle, Dauphinot, Luce, Pasteau, Fabien, Wehrle, Rosine, Larrat, Benoit, Vitalis, Tania, Moldrich, Randal X, Rossier, Jean, Sinkus, Ralph, Herault, Yann, Dusart, Isabelle, Potier, Marie-Claude
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2678156/
https://www.ncbi.nlm.nih.gov/pubmed/19331679
http://dx.doi.org/10.1186/1471-2164-10-138
_version_ 1782166830939373568
author Laffaire, Julien
Rivals, Isabelle
Dauphinot, Luce
Pasteau, Fabien
Wehrle, Rosine
Larrat, Benoit
Vitalis, Tania
Moldrich, Randal X
Rossier, Jean
Sinkus, Ralph
Herault, Yann
Dusart, Isabelle
Potier, Marie-Claude
author_facet Laffaire, Julien
Rivals, Isabelle
Dauphinot, Luce
Pasteau, Fabien
Wehrle, Rosine
Larrat, Benoit
Vitalis, Tania
Moldrich, Randal X
Rossier, Jean
Sinkus, Ralph
Herault, Yann
Dusart, Isabelle
Potier, Marie-Claude
author_sort Laffaire, Julien
collection PubMed
description BACKGROUND: Down syndrome is a chromosomal disorder caused by the presence of three copies of chromosome 21. The mechanisms by which this aneuploidy produces the complex and variable phenotype observed in people with Down syndrome are still under discussion. Recent studies have demonstrated an increased transcript level of the three-copy genes with some dosage compensation or amplification for a subset of them. The impact of this gene dosage effect on the whole transcriptome is still debated and longitudinal studies assessing the variability among samples, tissues and developmental stages are needed. RESULTS: We thus designed a large scale gene expression study in mice (the Ts1Cje Down syndrome mouse model) in which we could measure the effects of trisomy 21 on a large number of samples (74 in total) in a tissue that is affected in Down syndrome (the cerebellum) and where we could quantify the defect during postnatal development in order to correlate gene expression changes to the phenotype observed. Statistical analysis of microarray data revealed a major gene dosage effect: for the three-copy genes as well as for a 2 Mb segment from mouse chromosome 12 that we show for the first time as being deleted in the Ts1Cje mice. This gene dosage effect impacts moderately on the expression of euploid genes (2.4 to 7.5% differentially expressed). Only 13 genes were significantly dysregulated in Ts1Cje mice at all four postnatal development stages studied from birth to 10 days after birth, and among them are 6 three-copy genes. The decrease in granule cell proliferation demonstrated in newborn Ts1Cje cerebellum was correlated with a major gene dosage effect on the transcriptome in dissected cerebellar external granule cell layer. CONCLUSION: High throughput gene expression analysis in the cerebellum of a large number of samples of Ts1Cje and euploid mice has revealed a prevailing gene dosage effect on triplicated genes. Moreover using an enriched cell population that is thought responsible for the cerebellar hypoplasia in Down syndrome, a global destabilization of gene expression was not detected. Altogether these results strongly suggest that the three-copy genes are directly responsible for the phenotype present in cerebellum. We provide here a short list of candidate genes.
format Text
id pubmed-2678156
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-26781562009-05-07 Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development Laffaire, Julien Rivals, Isabelle Dauphinot, Luce Pasteau, Fabien Wehrle, Rosine Larrat, Benoit Vitalis, Tania Moldrich, Randal X Rossier, Jean Sinkus, Ralph Herault, Yann Dusart, Isabelle Potier, Marie-Claude BMC Genomics Research Article BACKGROUND: Down syndrome is a chromosomal disorder caused by the presence of three copies of chromosome 21. The mechanisms by which this aneuploidy produces the complex and variable phenotype observed in people with Down syndrome are still under discussion. Recent studies have demonstrated an increased transcript level of the three-copy genes with some dosage compensation or amplification for a subset of them. The impact of this gene dosage effect on the whole transcriptome is still debated and longitudinal studies assessing the variability among samples, tissues and developmental stages are needed. RESULTS: We thus designed a large scale gene expression study in mice (the Ts1Cje Down syndrome mouse model) in which we could measure the effects of trisomy 21 on a large number of samples (74 in total) in a tissue that is affected in Down syndrome (the cerebellum) and where we could quantify the defect during postnatal development in order to correlate gene expression changes to the phenotype observed. Statistical analysis of microarray data revealed a major gene dosage effect: for the three-copy genes as well as for a 2 Mb segment from mouse chromosome 12 that we show for the first time as being deleted in the Ts1Cje mice. This gene dosage effect impacts moderately on the expression of euploid genes (2.4 to 7.5% differentially expressed). Only 13 genes were significantly dysregulated in Ts1Cje mice at all four postnatal development stages studied from birth to 10 days after birth, and among them are 6 three-copy genes. The decrease in granule cell proliferation demonstrated in newborn Ts1Cje cerebellum was correlated with a major gene dosage effect on the transcriptome in dissected cerebellar external granule cell layer. CONCLUSION: High throughput gene expression analysis in the cerebellum of a large number of samples of Ts1Cje and euploid mice has revealed a prevailing gene dosage effect on triplicated genes. Moreover using an enriched cell population that is thought responsible for the cerebellar hypoplasia in Down syndrome, a global destabilization of gene expression was not detected. Altogether these results strongly suggest that the three-copy genes are directly responsible for the phenotype present in cerebellum. We provide here a short list of candidate genes. BioMed Central 2009-03-30 /pmc/articles/PMC2678156/ /pubmed/19331679 http://dx.doi.org/10.1186/1471-2164-10-138 Text en Copyright © 2009 Laffaire et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Laffaire, Julien
Rivals, Isabelle
Dauphinot, Luce
Pasteau, Fabien
Wehrle, Rosine
Larrat, Benoit
Vitalis, Tania
Moldrich, Randal X
Rossier, Jean
Sinkus, Ralph
Herault, Yann
Dusart, Isabelle
Potier, Marie-Claude
Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development
title Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development
title_full Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development
title_fullStr Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development
title_full_unstemmed Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development
title_short Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development
title_sort gene expression signature of cerebellar hypoplasia in a mouse model of down syndrome during postnatal development
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2678156/
https://www.ncbi.nlm.nih.gov/pubmed/19331679
http://dx.doi.org/10.1186/1471-2164-10-138
work_keys_str_mv AT laffairejulien geneexpressionsignatureofcerebellarhypoplasiainamousemodelofdownsyndromeduringpostnataldevelopment
AT rivalsisabelle geneexpressionsignatureofcerebellarhypoplasiainamousemodelofdownsyndromeduringpostnataldevelopment
AT dauphinotluce geneexpressionsignatureofcerebellarhypoplasiainamousemodelofdownsyndromeduringpostnataldevelopment
AT pasteaufabien geneexpressionsignatureofcerebellarhypoplasiainamousemodelofdownsyndromeduringpostnataldevelopment
AT wehrlerosine geneexpressionsignatureofcerebellarhypoplasiainamousemodelofdownsyndromeduringpostnataldevelopment
AT larratbenoit geneexpressionsignatureofcerebellarhypoplasiainamousemodelofdownsyndromeduringpostnataldevelopment
AT vitalistania geneexpressionsignatureofcerebellarhypoplasiainamousemodelofdownsyndromeduringpostnataldevelopment
AT moldrichrandalx geneexpressionsignatureofcerebellarhypoplasiainamousemodelofdownsyndromeduringpostnataldevelopment
AT rossierjean geneexpressionsignatureofcerebellarhypoplasiainamousemodelofdownsyndromeduringpostnataldevelopment
AT sinkusralph geneexpressionsignatureofcerebellarhypoplasiainamousemodelofdownsyndromeduringpostnataldevelopment
AT heraultyann geneexpressionsignatureofcerebellarhypoplasiainamousemodelofdownsyndromeduringpostnataldevelopment
AT dusartisabelle geneexpressionsignatureofcerebellarhypoplasiainamousemodelofdownsyndromeduringpostnataldevelopment
AT potiermarieclaude geneexpressionsignatureofcerebellarhypoplasiainamousemodelofdownsyndromeduringpostnataldevelopment